Hikal announces a leadership change

The cited disclosure explicitly identifies only Mr. Sameer Hiremath, Chairman and Managing Director, as authorized to determine materiality. It says that other executives were assigned roles, but the available passage does not name them or specify whether they are newly added under the updated policy. ^[1]

Comparison with the previous structure: the available evidence does not set out the prior authorization matrix, so a definitive Finance-versus-Legal-versus-Operations comparison cannot be made. In particular, the source does not establish that the CFO, Company Secretary, or an operations executive was newly authorized, nor does it identify any person removed from the earlier structure. The only clear change supported here is the express authorization of Sameer Hiremath; the source names of the additional authorized KMPs and the prior functional allocation could not be confirmed.

The specific percentage thresholds in Hikal’s updated Policy for Determination of Materiality could not be confirmed from the cited disclosure. The reported filing only states that Hikal authorised specified key managerial personnel to determine and disclose material events, in alignment with Regulation 30(5) of the SEBI (LODR) Regulations.^[1]

Accordingly, it would be unsafe to attribute the commonly cited SEBI quantitative thresholds to Hikal without the updated policy text or the relevant amendment notification. The available disclosure confirms the governance and authorisation framework, but not the turnover/net-worth percentages.

Verdict: The update appears to change who is authorised to assess and disclose material events, not what additional CDMO-specific events must be disclosed. Hikal’s 3 November 2026 announcement states that key managerial personnel were authorised to determine materiality and make stock-exchange disclosures in alignment with Regulation 30(5) of SEBI LODR; it does not enumerate additional operational or R&D triggers. ^[1]

What the Hikal update establishes

• Confirmed: a governance and delegation mechanism for Regulation 30 material-event disclosures, including authority assigned to senior personnel. ^[1]
• Not confirmed: an expanded policy covering specific CDMO events such as:
• major customer onboarding, technology-transfer or validation milestones;
• cancellation or delay of a development or commercial manufacturing programme;
• material changes in plant capacity, commissioning or utilisation;
• significant regulatory inspections, observations or quality failures;
• material R&D milestones, intellectual-property events or clinical-development programmes;
• major changes in customer concentration or project economics.

Those categories may be commercially relevant for a CDMO, but the cited Hikal announcement does not establish that they have been added to the company’s formal materiality framework. The distinction matters: Regulation 30 authorisation is a process requirement, whereas an explicit list of CDMO-specific triggers would represent a substantive expansion of disclosure policy.

Comparison with the named peers

Analyst implication

On the evidence available, Hikal should be viewed as having formalised disclosure responsibility, not as having demonstrably adopted a more expansive CDMO-transparency policy than its peers. A stronger conclusion would require the actual updated policy text or subsequent exchange filings showing that Hikal voluntarily reports operational and R&D milestones beyond the SEBI baseline.

The peer comparison is therefore not yet a disclosure-quality ranking: peer-specific policy language and examples of operational or R&D-related material-event reporting could not be confirmed for the five comparison companies.